Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FYQ13
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,463
Award facts
- Contract value 100% obligated
- $48,462.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $48,462.60 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 10 mg tablets (60-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its position under the DLA's larger SPE2DB Indefinite Delivery Contract valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group Inc. specializes in distributing a comprehensive portfolio of branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Jakafi is an oral medication used in the treatment of myelofibrosis and polycythemia vera, aligning with the company's established track record of supplying specialty pharmaceutical products to military health systems. The company's robust federal contract portfolio demonstrates consistent success in competing for pharmaceutical delivery orders without set-aside designations, supported by its woman-owned small business status and SAM.gov registration since 2001.
Quick answers
Who was awarded contract SPE2DB25FYQ13?
SPE2DB25FYQ13 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FYQ13 worth?
The government has obligated $48,463 on SPE2DB25FYQ13.
Is contract SPE2DB25FYQ13 an order under another contract?
Yes. SPE2DB25FYQ13 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ13 competed?
The extent of competition for SPE2DB25FYQ13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award